SAB298 suppressed cell proliferation as effectively as the ERK and MEK inhibitors (SCH772984 and AZD6244, respectively), which displayed wide range of activity when tested on our cohort of melanoma cells (IC50 12->10,000 nM) [7]. The gene discussed is MAPK1; the disease is melanoma.